Skip to content
Glycovax Pharma
  • ABOUT US
    • OVERVIEW
    • MANAGEMENT
    • SCIENTIFIC ADVISORS
    • BOARD OF DIRECTORS
  • COVID-19
  • SCIENCE
  • NEWS
  • CAREERS
  • CONTACT
  • Français

Press releases

Communiqué presse - press release

Glycovax Pharma develops a vaccine against COVID-19 – A semi-synthetic vaccine in the preclinical phase
04.21.2020
Download the press release here

Communiqué presse - press release

Glycovax Pharma Files a Patent Application for a New Semi-Synthetic Vaccine against Breast Cancers
04.04.2018
Download the press release here

GLYCOVAX PHARMA

The world’s elite in medicinal chemistry. We have designed a family of technology platforms in the world of nano-medicine, revolutionizing treatment of cancers and other diseases.

L’élite mondiale de la chimie médicinale. Nous avons conçu une famille de plateformes technologiques dans le monde de la nanomédecine, révolutionnant le traitement de cancers et autres maladies.
Linkedin
Facebook
Twitter
Linkedin
Facebook
Twitter

Copyright © 2020 Glycovax Pharma Inc. All rights reserved. / Tous droits réservés.